✦ LIBER ✦

Ibrutinib (PCI-32765) in Chronic Lymphocytic Leukemia

✍ Scribed by Jain, Nitin; O’Brien, Susan

Book ID: 121715549
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 372 KB
Volume: 27
Category: Article
ISSN: 0889-8588
DOI: 10.1016/j.hoc.2013.01.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ibrutinib in chronic lymphocytic leukemi

Ibrutinib in chronic lymphocytic leukemia and B cell malignancies

✍ Brown, Jennifer R. 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 210 KB

Targeting BTK with Ibrutinib in Relapsed

Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia

✍ Byrd, John C.; Furman, Richard R.; Coutre, Steven E.; Flinn, Ian W.; Burger, Jan 📂 Article 📅 2013 🏛 Massachusetts Medical Society 🌐 English ⚖ 745 KB

The emerging role of ibrutinib in the tr

The emerging role of ibrutinib in the treatment of chronic lymphocytic leukemia

✍ Molica, Stefano 📂 Article 📅 2013 🏛 Expert Reviews 🌐 English ⚖ 129 KB

The clinically active BTK inhibitor PCI-

The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia

✍ de Rooij, M. F. M.; Kuil, A.; Geest, C. R.; Eldering, E.; Chang, B. Y.; Buggy, J 📂 Article 📅 2012 🏛 American Society of Hematology 🌐 English ⚖ 504 KB

Bruton Tyrosine Kinase Inhibitor Ibrutin

Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies

✍ Advani, R. H.; Buggy, J. J.; Sharman, J. P.; Smith, S. M.; Boyd, T. E.; Grant, B 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 353 KB

Ibrutinib versus Ofatumumab in Previousl

Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia

✍ Byrd, John C.; Brown, Jennifer R.; O'Brien, Susan; Barrientos, Jacqueline C.; Ka 📂 Article 📅 2014 🏛 Massachusetts Medical Society 🌐 English ⚖ 660 KB